Kamnesh R Pradhan1, Yan Chen2, Sogol Moustoufi-Moab3, Kevin Krull4, Kevin C Oeffinger5, Charles Sklar6, Gregory T Armstrong4, Kirsten K Ness4, Leslie Robison4, Yutaka Yasui2,4, Paul C Nathan7. 1. Division of Pediatric Hematology-Oncology, Indiana University School of Medicine, Indianapolis, Indiana. 2. University of Alberta School of Public Health, Edmonton, Alberta, Canada. 3. Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. 4. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee. 5. Duke University School of Medicine, Durham, North Carolina. 6. Memorial Sloan-Kettering Cancer Center, New York, New York. 7. Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Abstract
CONTEXT: Childhood cancer survivors experience chronic health conditions that impact health-related quality of life (HRQOL) and participation in optimal physical activity. OBJECTIVE: The study aimed to determine independent effects of endocrine and metabolic disorders on HRQOL and physical activity. DESIGN, SETTING, AND PATIENTS: Retrospective cohort with longitudinal follow-up of survivors of childhood cancer enrolled in the North American Childhood Cancer Survivor Study. MAIN OUTCOME MEASURES: Medical Outcomes Short Form-36 estimated HRQOL, and participation in physical activity was dichotomized as meeting or not meeting recommendations from the Centers for Disease Control and Prevention. Log binomial regression evaluated the association of each endocrine/metabolic disorder with HRQOL scales and physical activity. RESULTS: Of 7287 survivors, with a median age of 32 years (range, 18 to 54 years) at their last follow-up survey, 4884 (67%) reported one or more endocrine/metabolic disorders. Survivors with either disorder were significantly more likely to be male, older, have received radiation treatment, and have experienced other chronic health conditions. After controlling for covariates, survivors with any endocrine/metabolic disorder were more likely to report poor physical function risk ratio (RR, 1.25; 95% CI, 1.05 to 1.48), increased bodily pain (RR, 1.27; 95% CI, 1.12 to 1.44), poor general health (RR, 1.49; 95% CI, 1.32 to 1.68), and lower vitality (RR, 1.21; 95% CI, 1.09 to 1.34) compared with survivors without. The likelihood of meeting recommended physical activity was lower among survivors with growth disorders (RR, 0.90; 95% CI, 0.83 to 0.97), osteoporosis (RR, 0.87; 95% CI, 0.76 to 0.99), and overweight/obesity (RR, 0.92; 95% CI, 0.88 to 0.96). CONCLUSION: Endocrine and metabolic disorders are independently associated with poor HRQOL and suboptimal physical activity among childhood cancer survivors.
CONTEXT: Childhood cancer survivors experience chronic health conditions that impact health-related quality of life (HRQOL) and participation in optimal physical activity. OBJECTIVE: The study aimed to determine independent effects of endocrine and metabolic disorders on HRQOL and physical activity. DESIGN, SETTING, AND PATIENTS: Retrospective cohort with longitudinal follow-up of survivors of childhood cancer enrolled in the North American Childhood Cancer Survivor Study. MAIN OUTCOME MEASURES: Medical Outcomes Short Form-36 estimated HRQOL, and participation in physical activity was dichotomized as meeting or not meeting recommendations from the Centers for Disease Control and Prevention. Log binomial regression evaluated the association of each endocrine/metabolic disorder with HRQOL scales and physical activity. RESULTS: Of 7287 survivors, with a median age of 32 years (range, 18 to 54 years) at their last follow-up survey, 4884 (67%) reported one or more endocrine/metabolic disorders. Survivors with either disorder were significantly more likely to be male, older, have received radiation treatment, and have experienced other chronic health conditions. After controlling for covariates, survivors with any endocrine/metabolic disorder were more likely to report poor physical function risk ratio (RR, 1.25; 95% CI, 1.05 to 1.48), increased bodily pain (RR, 1.27; 95% CI, 1.12 to 1.44), poor general health (RR, 1.49; 95% CI, 1.32 to 1.68), and lower vitality (RR, 1.21; 95% CI, 1.09 to 1.34) compared with survivors without. The likelihood of meeting recommended physical activity was lower among survivors with growth disorders (RR, 0.90; 95% CI, 0.83 to 0.97), osteoporosis (RR, 0.87; 95% CI, 0.76 to 0.99), and overweight/obesity (RR, 0.92; 95% CI, 0.88 to 0.96). CONCLUSION: Endocrine and metabolic disorders are independently associated with poor HRQOL and suboptimal physical activity among childhood cancer survivors.
Authors: Eric J Chow; Debra L Friedman; Yutaka Yasui; John A Whitton; Marilyn Stovall; Leslie L Robison; Charles A Sklar Journal: J Pediatr Date: 2007-04 Impact factor: 4.406
Authors: R R Pate; M Pratt; S N Blair; W L Haskell; C A Macera; C Bouchard; D Buchner; W Ettinger; G W Heath; A C King Journal: JAMA Date: 1995-02-01 Impact factor: 56.272
Authors: Melissa M Hudson; Kirsten K Ness; James G Gurney; Daniel A Mulrooney; Wassim Chemaitilly; Kevin R Krull; Daniel M Green; Gregory T Armstrong; Kerri A Nottage; Kendra E Jones; Charles A Sklar; Deo Kumar Srivastava; Leslie L Robison Journal: JAMA Date: 2013-06-12 Impact factor: 56.272
Authors: Sogol Mostoufi-Moab; Kristy Seidel; Wendy M Leisenring; Gregory T Armstrong; Kevin C Oeffinger; Marilyn Stovall; Lillian R Meacham; Daniel M Green; Rita Weathers; Jill P Ginsberg; Leslie L Robison; Charles A Sklar Journal: J Clin Oncol Date: 2016-07-05 Impact factor: 44.544
Authors: Corina S Rueegg; Micol E Gianinazzi; Johannes Rischewski; Maja Beck Popovic; Nicolas X von der Weid; Gisela Michel; Claudia E Kuehni Journal: J Cancer Surviv Date: 2013-06-20 Impact factor: 4.442
Authors: Lillian R Meacham; James G Gurney; Ann C Mertens; Kirsten K Ness; Charles A Sklar; Leslie L Robison; Kevin C Oeffinger Journal: Cancer Date: 2005-04-15 Impact factor: 6.921
Authors: Kirsten K Ness; K Scott Baker; Donald R Dengel; Nancy Youngren; Shalamar Sibley; Ann C Mertens; James G Gurney Journal: Pediatr Blood Cancer Date: 2007-12 Impact factor: 3.838
Authors: James G Gurney; Nina S Kadan-Lottick; Roger J Packer; Joseph P Neglia; Charles A Sklar; Judy A Punyko; Marilyn Stovall; Yutaka Yasui; H Stacy Nicholson; Suzanne Wolden; Dawn E McNeil; Ann C Mertens; Leslie L Robison Journal: Cancer Date: 2003-02-01 Impact factor: 6.921
Authors: Kamnesh R Pradhan; Yan Chen; Sogol Moustoufi-Moab; Kevin Krull; Kevin C Oeffinger; Charles Sklar; Gregory T Armstrong; Kirsten K Ness; Leslie Robison; Yutaka Yasui; Paul C Nathan Journal: J Clin Endocrinol Metab Date: 2019-11-01 Impact factor: 5.958
Authors: James R Day; Anu David; Catherine Long; Grace G Bushnell; Teresa K Woodruff; Lonnie D Shea; Ariella Shikanov Journal: Regen Med Front Date: 2019-09-16